Materials and information on the MitogenDx website are expressly deemed to be for general information purposes only and do not constitute medical or professional advice.
Autoimmune neuropathies can include Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and IgM paraproteinemic neuropathy, among others. They present with a broad range of symptoms, including slow or insidious onset and progression, asymmetric or multifocal nerve deficits, and selective involvement of motor, sensory, or autonomic nerves. The overlap of symptoms among syndromes often makes the diagnosis difficult. Presumptive diagnosis is based on the patient’s history and clinical signs and findings on physical exam. Initial laboratory testing aims to rule out underlying causes such as infections, metabolic disturbances, and brain tumors. If nothing is uncovered, further evaluation, including advanced imaging, nerve conduction studies, and cerebrospinal fluid (CSF) analysis may be required.
Autoimmune neuropathies can also arise as a condition associated with cancer (paraneoplastic). The detection of an autoantibody in the right clinical setting can provide evidence that the peripheral nerve disturbance is immune mediated and may direct treatment, but autoantibody testing cannot be used as the sole diagnostic tool. Anti-myelin-associated glycoprotein (anti-MAG) antibodies are often present in patients with predominant sensory symptoms, and anti-GM1 antibodies are present in patients with predominant motor nerve symptoms.
Guillain-Barré syndrome
CIDP (*Often confused with GBS, but symptoms continue for longer)
MMN